Tag: Vaccines
COVID-19 Vaccines Do Not Increase Risk for New Retinal Vascular Occlusion
Rates within 21 days of vaccination extremely rare and similar to those with influenza and Tdap vaccines
AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Combination of mRNA vaccine and pembrolizumab significantly prolongs recurrence-free survival versus pembrolizumab alone
Childbearing-Age Women Harbor Doubts About Vaccine Safety
Rates of concern higher than those of older women or men of any age
Parental Perceptions Affect Decision to Vaccinate Children Against COVID-19
Parents who are more concerned about long-term risk and report greater anticipated responsibility less likely to vaccinate
RSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine
RSVpreF Vaccine Found to Be Safe, Effective During Pregnancy
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants
WHO: Healthy Children, Teens May Not Need More COVID-19 Shots
Instead, COVID-19 vaccines should go to high-risk people, according to the agency's Strategic Advisory Group of Experts on Immunization
Electronic Reminders Boost Flu Vaccine Uptake in Older Adults
Letters highlighting potential cardiovascular benefits of influenza vaccination found to be particularly effective
Benefits of Maternal Immunization Against Group B Strep Explored
Net monetary benefit from group B Streptococcus vaccination estimated to range from $1.1 to $17 billion
Antibody Response Prolonged With COVID-19 Vaccine-Associated Symptoms
Increased likelihood of experiencing prolonged neutralizing antibody response seen for those with vaccine-associated symptoms, prior SARS-CoV-2 infection
